ALDX
Price:
$1.575
Market Cap:
$95.01M
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, includi...[Read more]
Industry
Biotechnology
IPO Date
2014-05-02
Stock Exchange
NASDAQ
Ticker
ALDX
According to Aldeyra The’s latest financial reports and current stock price. The company's current ROE is -57.34%. This represents a change of 309.03% compared to the average of -14.02% of the last 4 quarters.
The mean historical ROE of Aldeyra The over the last ten years is -63.29%. The current -57.34% ROE has changed -9.41% with respect to the historical average. Over the past ten years (40 quarters), ALDX's ROE was at its highest in in the December 2023 quarter at -3.97%. The ROE was at its lowest in in the September 2018 quarter at -37.81%.
Average
-63.29%
Median
-59.76%
Minimum
-126.51%
Maximum
-28.08%
Discovering the peaks and valleys of Aldeyra The ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 181.74%
Maximum Annual ROE = -28.08%
Minimum Annual Increase = -55.50%
Minimum Annual ROE = -126.51%
| Year | ROE | Change |
|---|---|---|
| 2025 | -76.49% | -2.76% |
| 2024 | -78.66% | 150.99% |
| 2023 | -31.34% | -23.70% |
| 2022 | -41.07% | 46.26% |
| 2021 | -28.08% | -55.50% |
| 2020 | -63.11% | -50.12% |
| 2019 | -126.51% | 181.74% |
| 2018 | -44.90% | -20.41% |
| 2017 | -56.42% | -34.68% |
| 2016 | -86.37% | 77.73% |
The current ROE of Aldeyra The (ALDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-62.16%
5-year avg
-51.13%
10-year avg
-63.29%
Aldeyra The’s ROE is greater than AC Immune S.A. (-123.98%), greater than Mereo BioPharma Group plc (-81.25%), greater than Silence Therapeutics plc (-121.71%), greater than Cellectis S.A. (-80.61%), greater than Genelux Corporation (-165.18%), greater than Contineum Therapeutics, Inc. (-24.73%), greater than Alto Neuroscience, Inc. (-47.22%), greater than Amarin Corporation plc (-5.99%), greater than Candel Therapeutics, Inc. (-60.42%), greater than Kyverna Therapeutics, Inc. (-81.87%),
| Company | ROE | Market cap |
|---|---|---|
| -123.98% | $235.61M | |
| -81.25% | $49.05M | |
| -121.71% | $518.63M | |
| -80.61% | $280.16M | |
| -165.18% | $114.34M | |
| -24.73% | $583.48M | |
| -47.22% | $981.58M | |
| -5.99% | $296.64M | |
| -60.42% | $760.19M | |
| -81.87% | $459.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aldeyra The using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aldeyra The or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aldeyra The's ROE?
How is the ROE calculated for Aldeyra The (ALDX)?
What is the highest ROE for Aldeyra The (ALDX)?
What is the 3-year average ROE for Aldeyra The (ALDX)?
What is the 5-year average ROE for Aldeyra The (ALDX)?
How does the current ROE for Aldeyra The (ALDX) compare to its historical average?